UL Solutions director reports dividend-equivalent stock unit accruals
UL Solutions Inc. director reports automatic stock-based accruals tied to deferred compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UL Solutions Inc. director reports automatic stock-based accruals tied to deferred compensation. On December 8, 2025, the reporting person received 8 dividend equivalent rights and 4 dividend equivalent rights on existing deferred restricted stock units, both with an exercise price of $0.
Each dividend equivalent right represents a contingent right to receive one share of UL Solutions Class A common stock and accrues when dividends are paid on the stock. These rights vest proportionately with the underlying deferred restricted stock units, which either vested on May 1, 2025 or will vest on the earlier of May 20, 2026 or the next annual meeting, and are expected to be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 8 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units | 4 | $0.00 | $0.00 |
Footnotes (5)
- F1. Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.
- F3. The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
- F4. Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.
- F5. The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UL Solutions (ULS) report in this Form 4?
How many dividend equivalent rights were credited to the UL Solutions director?
Did the UL Solutions director pay anything for these dividend equivalent rights?
When do the underlying deferred restricted stock units for the UL Solutions director vest?
How and when are the UL Solutions dividend equivalent rights expected to be settled?
Did this UL Solutions Form 4 disclose any sales of company stock by the director?
AI-generated analysis. How Rhea-AI works. Not financial advice.